A nanosensor probe that combines a tumour-targeting peptide, a diagnostic reporter and an imaging contrast agent enables early diagnosis, precision imaging, disease stratification and downstream therapeutic response monitoring of metastatic cancer.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Ofori, L. O. et al. ACS Chem. Biol. 10, 1977–1988 (2015).
Widen, J. C. et al. Nat. Biomed. Eng. 5, 264–277 (2021).
Hunt, J. F., Rath, P., Rothschild, K. J. & Engelman, D. M. Biochemistry 36, 15177–15192 (1997).
Weerakkody, D. et al. Proc. Natl Acad. Sci. USA 110, 5834–5839 (2013).
Hao, L. et al. Nat. Mater. https://doi.org/10.1038/s41563-021-01042-y (2021).
Buss, C. G., Dudani, J. S., Akana, R. T. K., Fleming, H. E. & Bhatia, S. N. EBioMedicine 38, 248–256 (2018).
Dudani, J. S., Ibrahim, M., Kirkpatrick, J., Warren, A. D. & Bhatia, S. N. Proc. Natl Acad. Sci. USA 115, 8954–8959 (2018).
Kirkpatrick, J. D. et al. Sci. Transl. Med. 12, eaaw0262 (2020).
Kwong, G. A. et al. Nat. Biotechnol. 31, 63–70 (2013).
Warren, A. D. et al. J. Am. Chem. Soc. 136, 13709–13714 (2014).
M.B. is a founder and consultant for Akrotome Imaging Inc. and is a consultant at Vergent Bioscience. Both companies are developing optical contrast agents that target lysosomal cysteine protease for imaging tumours during surgery.
Rights and permissions
About this article
Cite this article
Bogyo, M. A ‘Swiss army knife’ probe for metastatic cancers. Nat. Mater. 20, 1312–1314 (2021). https://doi.org/10.1038/s41563-021-01105-0